Position in NXL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$481
+$401 QoQ
Shares Held
49
+1533.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 20 holders
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $1,358,327,068 across 91 Medical Devices names. NXL ranks #87 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,621,398 | $237,865,653 | |
| 2 | SYK |
Stryker Corp
|
623,725 | $196,373,577 | |
| 3 | MDT |
Medtronic plc
|
1,848,092 | $144,576,236 | |
| 4 | PEN |
Penumbra Inc
|
433,125 | $136,759,218 | |
| 5 | BSX |
Boston Scientific Corp
|
2,582,561 | $110,223,702 | |
| 6 | EW |
Edwards Lifesciences Corp
|
1,199,364 | $108,494,465 | |
| 7 | DXCM |
Dexcom Inc
|
956,398 | $64,413,403 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
850,374 | $54,432,438 |
All Filings in NXL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481 | 1,459 | Shares | Defined | 2026-08-03 | |
| 2025-09-30 | $80 | 88 | Shares | Defined | 2025-11-10 | |
| 2024-06-30 | $1 | 1 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||